Breaking News Instant updates and real-time market news.

ACRS

Aclaris Therapeutics

$27.02

1.04 (4.00%)

18:35
11/21/16
11/21
18:35
11/21/16
18:35

Vivo Ventures VII reports 15.3% stake in Aclaris Therapeutics

ACRS Aclaris Therapeutics
$27.02

1.04 (4.00%)

09/19/16
JEFF
09/19/16
NO CHANGE
Target $31
JEFF
Buy
Aclaris Therapeutics price target raised to $31 from $23 at Jefferies
Jefferies analyst David Steinberg raised his price target for Aclaris Therapeutics to $31 saying he's "increasingly optimistic" about the outlook for a second indication for A-101 after the company last week released additional information on the common wart Phase 2 study. The sustainability of the franchise could be further bolstered by new patents, Steinberg tells investors in a research note. He raised his peak sales estimate for A-101 to $250M from $75M and keeps a Buy rating on Aclaris.
09/30/16
JMPS
09/30/16
INITIATION
JMPS
Outperform
Aclaris Therapeutics initiated with an Outperform at JMP Securities
JMP Securities analyst Donald Ellis started coverage of Aclaris with a $34 price target.
11/16/16
JEFF
11/16/16
NO CHANGE
Target $32
JEFF
Buy
Aclaris Therapeutics price target raised to $32 from $29 at Jefferies
Jefferies analyst David Steinberg raised his price target for Aclaris Therapeutics to $32 saying A-101 for seborrheic keratosis looks approvable following yesterday's positive Phase III data. The analyst believes the data readout is a "significant de-risking event" for Aclaris and sees potential peak sales of $500M-plus. He adds that the company fits with his firm's M&A thesis. Steinberg reiterates a Buy rating on Aclaris.
11/16/16
JMPS
11/16/16
NO CHANGE
JMPS
Aclaris Therapeutics price target raised to $39 from $34 at JMP Securities
JMP Securities analyst Donald Ellis says that data for Aclaris' A-101 drug was "highly positive" and he thinks that the drug is "substantially derisked." The analyst thinks that there is an 80% chance of the drug being approved, and he keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

GPMT

Granite Point Mortgage

09:44
06/23/17
06/23
09:44
06/23/17
09:44
Syndicate
Breaking Syndicate news story on Granite Point Mortgage »

Granite Point Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

GPMT

Granite Point Mortgage

09:43
06/23/17
06/23
09:43
06/23/17
09:43
Syndicate
Breaking Syndicate news story on Granite Point Mortgage »

Granite Point Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

MDSO

Medidata

$80.25

4.25 (5.59%)

09:42
06/23/17
06/23
09:42
06/23/17
09:42
Conference/Events
Medidata management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

LPI

Laredo Petroleum

09:41
06/23/17
06/23
09:41
06/23/17
09:41
Conference/Events
Laredo Petroleum management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

IFF

International Flavors

09:41
06/23/17
06/23
09:41
06/23/17
09:41
Hot Stocks
International Flavors to settle trade secret lawsuit with ZoomEssence for $56M »

ZoomEssence and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPMT

Granite Point Mortgage

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Syndicate
Granite Point Mortgage indicated to open at $18-$19, IPO priced at $19.50 »

Granite Point Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

LGF.A

Lionsgate

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Conference/Events
Lionsgate management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

NGD

New Gold

, GILD

Gilead

$70.48

2.98 (4.41%)

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Options
Unusually active option classes on open June 23rd »

Unusual total active…

NGD

New Gold

GILD

Gilead

$70.48

2.98 (4.41%)

ORCL

Oracle

VRX

Valeant

AMD

AMD

$14.38

0.4 (2.86%)

DIS

Disney

SLV

iShares Silver Trust

CAT

Caterpillar

COST

Costco

$159.79

-3.36 (-2.06%)

TWTR

Twitter

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 19

    Jul

  • 08

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

STML

Stemline

$8.50

0.15 (1.80%)

09:39
06/23/17
06/23
09:39
06/23/17
09:39
Hot Stocks
Stemline presents updated stage 1 and 2 data from SL-401 trial »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Sep

LGF

Use LGF.A, LGF.B

09:39
06/23/17
06/23
09:39
06/23/17
09:39
Conference/Events
Use LGF.A, LGF.B management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

INN

Summit Hotel Properties

09:38
06/23/17
06/23
09:38
06/23/17
09:38
Conference/Events
Summit Hotel Properties management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 13

    Jul

IMGN

ImmunoGen

$5.82

-0.2 (-3.32%)

09:38
06/23/17
06/23
09:38
06/23/17
09:38
Conference/Events
ImmunoGen management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

REGN

Regeneron

$526.53

4.51 (0.86%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Hot Stocks
Breaking Hot Stocks news story on Regeneron »

Regeneron down 4.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$14.68

0.48 (3.38%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Periodicals
Several private equity firms have reached out to Etsy, Dealreporter says »

While Etsy has not been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Technical Analysis
Technical View: Caterpillar slips lower, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQY

HealthEquity

$51.05

-0.39 (-0.76%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Conference/Events
HealthEquity management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

APLP

Archrock Partners LP

$13.66

0.61 (4.67%)

09:35
06/23/17
06/23
09:35
06/23/17
09:35
Downgrade
Archrock Partners LP rating change  »

Archrock Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
06/23/17
06/23
09:35
06/23/17
09:35
General news
U.S. new home sales preview: »

U.S. new home sales…

AROC

Archrock

09:34
06/23/17
06/23
09:34
06/23/17
09:34
Downgrade
Archrock rating change  »

Archrock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRE

Washington REIT

09:32
06/23/17
06/23
09:32
06/23/17
09:32
Conference/Events
Washington REIT management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 28

    Jul

  • 27

    Oct

09:30
06/23/17
06/23
09:30
06/23/17
09:30
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

June PMI Composite Flash…

09:30
06/23/17
06/23
09:30
06/23/17
09:30
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

June PMI Composite Flash…

ADHD

Alcobra

, AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

09:29
06/23/17
06/23
09:29
06/23/17
09:29
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Alcobra (ADHD),…

ADHD

Alcobra

AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

SNCR

Synchronoss

$12.18

1.53 (14.37%)

BBRY

BlackBerry

$11.06

0.41 (3.85%)

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

BLCM

Bellicum Pharmaceuticals

$13.98

1.33 (10.51%)

BLUE

bluebird bio

$118.50

-1.8 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 23

    Jun

  • 29

    Jun

  • 26

    Sep

RIO

Rio Tinto

, GLNCY

Glencore

$7.10

0.05 (0.71%)

09:29
06/23/17
06/23
09:29
06/23/17
09:29
Hot Stocks
Glencore raises offer for Rio Tinto's Coal & Allied to $2.675B plus royalties »

Glencore (GLNCY)…

RIO

Rio Tinto

GLNCY

Glencore

$7.10

0.05 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$149.69

0.27 (0.18%)

09:28
06/23/17
06/23
09:28
06/23/17
09:28
Conference/Events
Stifel medical technology analysts hold an analyst/industry conference call »

Research Team discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.